LICENSE AGREEMENTLicense Agreement • March 20th, 2017 • Newlink Genetics Corp • Pharmaceutical preparations • Delaware
This license agreement (the “Agreement”) is made and is effective as of March 19, 2017 (the “Effective Date”) between BlueLink Pharmaceuticals, Inc. (“Licensee”) and Cerulean Pharma Inc. (“Licensor”). Licensee and Licensor are each referred to as a “Party” and collectively referred to as the “Parties.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 20th, 2017 • Newlink Genetics Corp • Pharmaceutical preparations • Delaware
Asset Purchase Agreement (“Agreement”), dated March 19, 2017 (the “Effective Date”) between BlueLink Pharmaceuticals, Inc., a Delaware corporation (“COMPANY”) and Cerulean Pharma Inc., a Delaware corporation (“Cerulean”). COMPANY and Cerulean are each separately referred to as a “Party” and are collectively referred to as the “Parties”.
